JPS6365050B2 - - Google Patents

Info

Publication number
JPS6365050B2
JPS6365050B2 JP57180547A JP18054782A JPS6365050B2 JP S6365050 B2 JPS6365050 B2 JP S6365050B2 JP 57180547 A JP57180547 A JP 57180547A JP 18054782 A JP18054782 A JP 18054782A JP S6365050 B2 JPS6365050 B2 JP S6365050B2
Authority
JP
Japan
Prior art keywords
composition
antiviral
interferon
surfactant
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57180547A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5877824A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5877824A publication Critical patent/JPS5877824A/ja
Publication of JPS6365050B2 publication Critical patent/JPS6365050B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP57180547A 1981-10-13 1982-10-13 インターフェロンを含む組成物 Granted JPS5877824A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31103581A 1981-10-13 1981-10-13
US311035 1981-10-13
US388260 2003-03-13

Publications (2)

Publication Number Publication Date
JPS5877824A JPS5877824A (ja) 1983-05-11
JPS6365050B2 true JPS6365050B2 (en, 2012) 1988-12-14

Family

ID=23205109

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57180547A Granted JPS5877824A (ja) 1981-10-13 1982-10-13 インターフェロンを含む組成物

Country Status (2)

Country Link
JP (1) JPS5877824A (en, 2012)
CA (1) CA1190148A (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0285443U (en, 2012) * 1988-12-22 1990-07-04

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080032A3 (en) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmaceutical preparation for treating herpetic lesions
DE3436638C2 (de) * 1984-10-05 1992-10-08 Bioferon biochemische Substanzen GmbH & Co, 7958 Laupheim Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen
JPS61277633A (ja) * 1985-05-31 1986-12-08 Toray Ind Inc インタ−フエロン組成物
JPS62185030A (ja) * 1986-02-07 1987-08-13 Toray Ind Inc 経鼻投与用インタ−フエロン製剤
CA1294215C (en) * 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
CA1321347C (en) * 1986-11-10 1993-08-17 David C. Munch Human leukocyte interferon composition and skin treatment
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
AP132A (en) * 1990-02-01 1991-05-19 Kenya Medical Res Institute Improved formulation of low-dose interferon alpha.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4184917A (en) * 1974-04-01 1980-01-22 Sandoz Ltd. Process for producing a structurally modified interferon
US4020183A (en) * 1974-12-03 1977-04-26 Ortho Pharmaceutical Corporation Nonionic surface active anti-herpes simplex viral agents
JPS5283936A (en) * 1976-01-01 1977-07-13 Ortho Pharma Corp Single herpes virus inactivating acent
JPS5562024A (en) * 1978-10-31 1980-05-10 Hayashibara Takeshi Preventive and remedy for interferon-sensitive disease
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor
JPS55102519A (en) * 1979-01-31 1980-08-05 Green Cross Corp:The Stabilization of interferon
MW2880A1 (en) * 1979-07-31 1981-12-09 Hoffmann La Roche Homogeneous fibroblast interferon and method for manufacture thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0285443U (en, 2012) * 1988-12-22 1990-07-04

Also Published As

Publication number Publication date
CA1190148A (en) 1985-07-09
JPS5877824A (ja) 1983-05-11

Similar Documents

Publication Publication Date Title
US4507281A (en) Interferon-containing compositions
EP0077063B1 (en) Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
US4309989A (en) Topical application of medication by ultrasound with coupling agent
CA1083040A (en) Topical application of medication by ultrasound with coupling agent
AU746756B2 (en) A method of inhibiting formation of infectious herpes virus particles
CA1297006C (en) Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
GB2078515A (en) Topical anti-viral preparation
MXPA00009705A (es) Uso de poliaminas en el tratamiento de sintomas dermatologicos.
JPH0739347B2 (ja) 硫酸化糖類の用途
EP1094807B1 (en) Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies
US4957734A (en) Treatment of certain skin malignancies and pre-malignant skin lesions, herpes zoster and psoriasis
US4708873A (en) Method of chemically debriding uncerated necrotic tissue
JPS6365050B2 (en, 2012)
US4049798A (en) Method for the treatment of Herpes Simplex
JP3180221B2 (ja) ヘルペス・シンプレックス・ウィルス感染治療用医薬組成物
JPS58103324A (ja) インタ−フエロン組成物及びヘルペス感染症の治療における該組成物の使用
US5106879A (en) Treatment for inflammatory skin disease
US5977176A (en) Compositions for the treatment of warts and herpes
Nelson et al. Clinical aspects of cutaneous leishmaniasis acquired in Texas
JPH03500656A (ja) ウイルス感染の治療および予防薬剤アシル・カルニチン
EP0078533B1 (en) Medicinal composition for treating skin disorders
US8492443B2 (en) Treatment for herpes simplex virus and other infectious diseases
CA1227754A (en) Use of tolnaftate in the treatment of herpes labialis
CA1260397B (en) Treatment of acne and perioral dermatitis as well as for skin infected with a herpesvirus
CA1184121A (en) Treatment of acne and perioral dermatitis as well as for skin infected with a herpesvirus